Drug intelligence / Profile preview

ALPHAMITS

Development stage
Unknown
Lead developer
Mits Healthcare
Modality
Small Molecules
Administration
Oral
01

Overview

ALPHAMITS is a nutritional supplement containing alpha keto-analogues of essential amino acids, developed and manufactured by MITS Healthcare. It is primarily indicated for the management of chronic kidney disease (CKD) and liver disease, typically used in conjunction with a low-protein diet. The drug works by providing essential amino acids in their keto or hydroxy forms, which do not contain nitrogen. These analogues are transaminated into active essential amino acids by utilizing nitrogen from non-essential amino acids or urea, thereby reducing the accumulation of toxic nitrogenous waste products in patients with impaired renal or hepatic function. This metabolic process helps maintain proper protein nutrition while slowing the progression of kidney disease and delaying the need for dialysis initiation.

Brand names
ALPHAMITS
Other names
alpha ketoanalogue tabletsalpha keto-analogue amino acids

Beyond the preview

Go deeper on ALPHAMITS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALPHAMITS.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call